openPR Logo
Press release

Metominostrobin Market Is Likely to Register Double Digit CAGR During2018-2027

07-27-2018 04:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Metominostrobin Market Is Likely to Register Double Digit CAGR

The global metominostrobin market report by Fact.MR is a complete market research analysis. Study of past, present, and future trends of the industry offers a comprehensive outlook of the growth of the global metominostrobin market during the forecast period between 2018 and 2027.

Request Brochure of The Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=687

Amidst the challenge of increased productivity, global agricultural sector is seeking novel and effective pesticides to protect the crop and increase the yield. Population growth, changing tastes, and technology advances in the agricultural sector have significantly contributed to the management of increased productivity pressure. And these factors, in turn, hold significant influence over the growth of the global metominostrobin market.

Developed since 1996, Metominostrobin is classified under the most common fungicide group called strobilurins. Strobilurins are, in turn, classified under QoI or quinone outside inhibitor according to their mode of action. Metominostrobin is a broad-spectrum, systemic, preventive, and curative fungicide applied to control the fungal diseases in rice, wheat, soya bean, cotton, kidney beans, and corn. The first commercial metominostrobin was made available in market by Shionogi in 1999. Primarily designed for rice crop, this fungicide is under study for its utilization in other crops as well.

In 2014, Sumitomo Agro International, a subsidiary of Sumitomo Corporation acquired Bayer Crop Science Japan’s metominostrobin. The acquisition allowed Sumitomo to distribute and market the fungicide, however, the sales and development of the metominostrobin were retained by Bayer Crop Science. In 2017, both the organizations have agreed to initiate joint efforts to develop new fungicides to control soya bean disease in Brazil.

As of 2018, key stakeholders in the global metominostrobin market include Summit Agro China, Sumitomo Corporation, Bayer Crop Science, Shionogi, Syngenta, and Jiangsu Furun Biochemical Technology among others.

The agriculture community is expected to feed approximately 9.7 billion global population in 2050. To accommodate this demand, a two-fold rise in the cereal crop production is expected from farmer’s community. Due to this, increased productivity has become an important challenge. With the aim of higher yield production, the community has actively adopted modern farming methods including use of chemicals such as pesticides and fungicides. Following this trend, the market for metominostrobin is likely to witness persistent growth in future.

Recently, Sumitomo’s metominostrobin has received approval from the National Health Surveillance Agency (Anvisa) in Brazil, the second largest soya bean producing country. The approval covers foliar application of the fungicide on six crops including corn, soya bean, rice, wheat, cotton, and kidney beans. Argentina, world’s leading soya bean producer, has already received a registration approval for metominostrobin as a Crop Protection product. Along with Argentina and other Latin American countries including Columbia, Peru, Eucador, and Bolivia are leading soya bean producers across the globe have also received the approval. Asian Fruit and cereal producers such as Vietnam, Philippines, Indonesia, Malaysia and other important rice cultivators including India, Pakistan and Shri Lanka have a significant market presence of metominostrobin.

Over 60% of the world population relies on rice that serves as a staple food for major world communities. Out of total world rice grain production, approximately 90% is produced as well as consumed in Asia, helmed by India. According to Foreign Agricultural services, USDA, in the month if April 2018, higher rice production was reported in Asian countries such as Pakistan, Philippines, Shri Lanka, and other world countries such as Brazil, Columbia, and Burma. Several studies have shown effective fungal disease control in rice with the use of metominostrobin as compared to other fungicides available in the market. As it provides effective disease control and gives higher grain yield, metomionostrobin is highly preferred in paddy fields.

Rice blast caused by Magnaporthe oryzae is the most important rice disease destroying almost every plant part such as leaves, stems, peduncles, seeds, panicles, and also roots. Although chemical control assists in management of such fungal diseases, the rice crop remains vulnerable to the disease, due to pathogen’s ability to rapidly adapt and alter genetic composition for survival. Development of resistant strain or hybrid combinations is effective and economical for disease management. Owing to which, several R&D efforts are underway to develop resistant strains. As these strains are intrinsically resistant to fungal pathogens, if successfully developed, demand for fungicides including metominostrobin may decline in future.

Request Report TOC: https://www.factmr.com/connectus/sample?flag=T&rep_id=687

Above discussed market scenarios are thoroughly discussed in the report making it the most credible source for business professionals to understand the outlook of the global metominostrobin market.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metominostrobin Market Is Likely to Register Double Digit CAGR During2018-2027 here

News-ID: 1150608 • Views: 154

More Releases from Fact.MR

10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated

All 5 Releases


More Releases for Metominostrobin

Global Metominostrobin Market Forecast Covering Growth Inclinations & Developmen …
The global Metominostrobin Market is predicted to increase growth with rising focus on research and development. The curative and preventative activities of metominostrobin could attract a whole lot of demand in the market. The fungicide’s residual activity could last close to 50 days and could be directly applied to paddy water or to foliage. Oribright is one of the new metominostrobin fungicides used to control rice blast. It is recommended
Metominostrobin Market Greater Revenue Share by 2018 to 2027
The global metominostrobin market report by Fact.MR is a complete market research analysis. Study of past, present, and future trends of the industry offers a comprehensive outlook of the growth of the global metominostrobin market during the forecast period between 2018 and 2027. Amidst the challenge of increased productivity, global agricultural sector is seeking novel and effective pesticides to protect the crop and increase the yield. Population growth, changing tastes, and
Emerging Trends: Metominostrobin Market By Key Players: Shionogi, Syngenta, Baye …
Qyresearchreports include new market research report Metominostrobin to its huge collection of research reports. The international market for Metominostrobin has been researched in detail in the publication with increased focus on important factors such as opportunities, and restraints, growth drivers. Each of the factors that pertain to shaping of the market dynamics has been studied and analyzed in detail by the analysts, so as to offer the best and most evaluative
New Research on Global Metominostrobin Market Highlights Growth Overview and Est …
The global metominostrobin market report by Fact.MR is a complete market research analysis. Study of past, present, and future trends of the industry offers a comprehensive outlook of the growth of the global metominostrobin market during the forecast period between 2018 and 2027. Amidst the challenge of increased productivity, global agricultural sector is seeking novel and effective pesticides to protect the crop and increase the yield. Population growth, changing tastes, and
Metominostrobin Market Report, History and Forecast 2013-2025: QY Research
This report studies the Metominostrobin market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The global Metominostrobin market was million US$ in 2017 and is expected to million US$ by the end
Global Metominostrobin Industry Assessment & Market Growth Evolution Forecasted …
As per the current market trends and the promising nature of the global metominostrobin market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Fact.MR would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various facets of the market during